NTRBW logo

Nutriband (NTRBW) Stock

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

01 October 2021

Indexes:

Not included

Description:

Nutriband (NTRBW) is a company focused on developing innovative transdermal drug delivery systems. They create wearable patches that deliver medications through the skin, improving patient compliance and comfort. Their technology aims to enhance treatment effectiveness and provide convenient solutions for various health conditions.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

N/A

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Aug 15, 2022

Analyst ratings

Recent major analysts updates

No data about analysts updates

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Similar stocks

Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology
Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology
Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology
NTRBW
globenewswire.com27 November 2024

ORLANDO, Fla., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of prescription transdermal pharmaceutical products, today announced that it has received a Notice of Publication of the Registration and Grant of a Standard Patent (R) from the Hong Kong Intellectual Property Department for patent application entitled, “Abuse and Misuse Deterrent Transdermal Systems,” which protects its AVERSA™ abuse deterrent transdermal technology.

Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application
Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application
Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application
NTRBW
accesswire.com31 October 2024

ORLANDO, FL / ACCESSWIRE / October 31, 2024 / Nutriband (NASDAQ:NTRB)(NASDAQ:NTRBW), has announced that theChinese National Intellectual Property Administrant (CNIPA) has fully issued its patent titled "Abuse and Misuse Deterrent Transdermal System" which is related to the Company's lead technology AVERSA™. The patent underpins 4p Therapeutics' abuse deterrent transdermal system, AVERSA, which uses taste aversion to address the primary routes of abuse for opioid based transdermal patches.

Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica
Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica
Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica
NTRBW
accesswire.com17 October 2024

The approved product will be exclusively distributed through Farmavision S.A. throughout Costa Rica ORLANDO, FL / ACCESSWIRE / October 17, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), today announced that it has received approval from the Costa Rica Ministry of Health for the production and marketing of its Mosquito Repellent Patch, designed to reduce the risk of mosquito bites and associated health risks associated with exposure to mosquito bites.

FAQ

  • What is the primary business of Nutriband?
  • What is the ticker symbol for Nutriband?
  • Does Nutriband pay dividends?
  • What sector is Nutriband in?
  • What industry is Nutriband in?
  • What country is Nutriband based in?
  • When did Nutriband go public?
  • Is Nutriband in the S&P 500?
  • Is Nutriband in the NASDAQ 100?
  • Is Nutriband in the Dow Jones?
  • When does Nutriband report earnings?

What is the primary business of Nutriband?

Nutriband (NTRBW) is a company focused on developing innovative transdermal drug delivery systems. They create wearable patches that deliver medications through the skin, improving patient compliance and comfort. Their technology aims to enhance treatment effectiveness and provide convenient solutions for various health conditions.

What is the ticker symbol for Nutriband?

The ticker symbol for Nutriband is NASDAQ:NTRBW

Does Nutriband pay dividends?

No, Nutriband does not pay dividends

What sector is Nutriband in?

Nutriband is in the Healthcare sector

What industry is Nutriband in?

Nutriband is in the Biotechnology industry

What country is Nutriband based in?

Nutriband is headquartered in United States

When did Nutriband go public?

Nutriband's initial public offering (IPO) was on 01 October 2021

Is Nutriband in the S&P 500?

No, Nutriband is not included in the S&P 500 index

Is Nutriband in the NASDAQ 100?

No, Nutriband is not included in the NASDAQ 100 index

Is Nutriband in the Dow Jones?

No, Nutriband is not included in the Dow Jones index

When does Nutriband report earnings?

The date for Nutriband's next earnings report has not been announced yet